HSE•AG specializes in automating life sciences and analytics, translating complex laboratory workflows into automation solutions in regulated environments.

HSE•AG

Open Text Corporation engages in the designs, develops, markets, and sells information management software and solutions. It offers content services; business network that manages data within the organization and outside the firewall; security and protection solutions for defending against cyber threats, and preparing for business continuity and response in the event of a breach; digital investigation and forensic security solutions; OpenText security solutions to address information cyber resilience needs; Carbonite and Webroot products; and OpenText Information Management software platform. The company also provides eDiscovery platform that provides forensics and unstructured data analytics; OpenText Developer Cloud; key developer API services; AI and analytics that leverages structured or unstructured data; digital process automation solutions, which enables organizations to transform into digital data-driven businesses; and OpenText Digital Experience platform. In addition, it offers customer support programs, including access to software upgrades, a knowledge base, discussions, product information, and an online mechanism to post and review trouble tickets; and consulting and learning services relating to the implementation, training, and integration of its licensed product offerings, as well as cloud services. The company serves organizations, enterprise and mid-market companies, public sector agencies, small and medium-sized businesses, and direct consumers in Canada, the United States, the United Kingdom, Germany, rest of Europe, the Middle East, Africa, and internationally. It has strategic partnerships with SAP SE, Google Cloud, Amazon AWS, Microsoft Corporation, Oracle Corporation, Salesforce.com Corporation, Accenture plc, ATOS, Capgemini Technology Services SAS, Cognizant Technology Solutions U.S. Corp., Deloitte Consulting LLP, and Tata Consultancy Services. Open Text Corporation was incorporated in 1991 and is headquartered in Waterloo, Canada.

Open Text Corporation

Urbint leverages real-world data and artificial intelligence to predict and prevent incidents that threaten critical infrastructure, workers, the community, and the environment. They provide solutions for underground utilities, worker safety, and damage prevention.

Urbint

HSE•AG | 2,484 followers on LinkedIn. Enabling and simplifying the automation of molecular and systems biology analyses | HSE•AG: Unraveling the Mysteries of Life, Enabling the next Breakthrough in Life Science.

At HSE•AG, we&#39;re more than just an engineering service provider; we&#39;re pioneers in the life science and diagnostics industries. Our mission?

Innovation and entrepreneurship is my life

Hans Noser

Chief Commercial Officer at HSE

Patrick Widler

Project Manager at HSE•AG

David Smith

Driving innovative Business

Alexander Ferro

Enhancing Our Expertise: Life Science Automation Meets Cell & Gene Therapy Eight years ago, Michael Collasius and Hans Noser laid the foundation for our journey in life science automation at the HSE•AG. Thanks to our extensive experience in sample preparation and analysis, we have recently expanded our services in the pioneering field of creating tailored solutions for personalized patient treatment in the pharmaceutical industry. We're proud to play a key role in bridging the gap between laboratory analysis and the pharmaceutical industry, ensuring the highest standards of precision and automation. Thank you to our team, clients and partners for being part of our story. Read more in our blog: https://lnkd.in/dA6Da268 #HSEAG #8YearsOfInnovation #CellAndGeneTherapy #QualityControl #Automation

Inside HSE•AG – meet Max Max Köhl is a Requirement and Test Engineer at HSE. Discover in his interview why HSE ticks all the boxes and how his hobby allows him to dive into tranquility. Discover more about Max in our blog: https://bit.ly/4eunird #HSEAG #InsideHSE #HSELife

Wrapping up an inspiring time at ASHG 2024 in Denver! It was a pleasure reconnecting with familiar faces and meeting new ones, sharing insights, and exploring opportunities in human genetics. We had the chance to introduce some new potential customers to the eviFluor fluorescence reader, a tool enabling rapid, precise on-deck fluorescence detection for DNA, RNA, and protein applications. Thank you to everyone who took the time to chat with us – your enthusiasm and ideas made it a memorable experience! #ASHG2024 #HumanGenetics #Networking

Our fluidics expert Dr. Thomas Müller has identified 10 success factors for fluidics development projects in the life sciences and diagnostics industries. Technical engineering expertise alone is not sufficient to combine the sometimes-conflicting needs under one system umbrella. Explore the 10 factors for success in our blog: https://bit.ly/3CcpiH0 #HSEAG #Fluidics #LifeSciencesAndDiagnostics #DevelopmentProject #MaterialCompatibility

🚀SPEED TO SUCCESS with Cost-Effective Concepts and Demonstrators🚀 Securing financial resources is challenging. As a development service provider with 30+ years of expertise in molecular diagnostics, protein, and cell analysis, we help you realize initial concepts and functional demonstrators in a couple of weeks. CONVINCING DECISION MAKERS NEED TRUST: ▪️Comprehensive Planning: Detailed timelines and resource estimates. ▪️Cost-Benefit Analyses: Justify financial value and long-term benefits. ▪️Risk Management: Mitigate project and technological risks. OUR APPROACH: MAKE THE DECISION MAKER UNDERSTAND ▪️Consultation: Understand project goals and requirements. ▪️Concept Development: Craft initial product concepts with detailed project plans. ▪️Rapid Prototyping: Develop a functional demonstrator within weeks. YOU BENEFITS: UNDERSTANDING NEEDS EXCELLENT INFORMATION ✔️ Early Feedback: Gather insights from stakeholders and end-users. ✔️ Demonstrate Feasibility: Show practical and achievable ideas. ✔️ Highlight Value: Illustrate financial and operational benefits. ✔️ Reduce Risks: Provide tangible examples to mitigate concerns. SUCCESS STORIES: We've enabled firms to present functional demonstrators in a few weeks, securing critical investments and advancing projects rapidly. Experience the difference rapid and cost-effective development can make for your project and budget approval. 📖 Read our blog: Cost-Effective Demonstrators for Budget Approval: https://bit.ly/4fsVS5Y #HSEAG #Innovation #LifeSciences #Diagnostics #FunctionalDemonstrator #BudgetApproval

We can’t wait to attend the Precision Liquid Handling Workshop 2024 on 19 November in Zurich. This is a fantastic opportunity to dive into the innovative liquid handling technologies that are transforming academia and industry. We’d love to connect with other attendees during this inspiring workshop to share knowledge and insights. Schedule a meeting with us: https://bit.ly/4dZlGVZ #HSEAG #CSEM #LiquidHandling #LabAutomation

We’re thrilled to announce that we will be attending the AMP 2024 Annual Meeting & Expo in Vancouver, BC, Canada. This event, from 19–23 November, promotes education as well as networking and collaboration with leading molecular professionals around the globe. We are keen to engage with other attendees during the event. If you want to explore innovative automation that can transform your molecular pathology workflows, let’s collaborate. Schedule a meeting with us: https://bit.ly/3BYrba0 #HSEAG #AMPATH24 #Engineering

We’re pleased to share that we will be attending MEDICA 2024 in Düsseldorf from 11–14 November. This global event showcases pioneering innovations in diagnostics, digital health, and medical devices. If you’ll be there, why not join us and explore how we can shape the future of diagnostics and personalized medicine together. Schedule a meeting with us: https://bit.ly/3U1Ez3v #HSEAG #MEDICA #Engineering #LifeSciences

We’ll be at ASHG 2024 in Denver, CO from 5–9 November. This meeting is an amazing opportunity to dive into the latest insights and advancements in human genetics and genomics. It’s always great to see familiar faces and to make new connections. Let’s meet and explore how we can push the boundaries of human genetics together. Schedule a meeting with us: https://bit.ly/4gQ7mSo #HSEAG #ASHG24 #HumanGenetics #Engineering #LifeSciences

Inside HSE•AG – meet Lukas Lukas Vaut is a Systems Engineer at HSE. In our interview he explains how he enjoys two passions as a hybrid professional and rocks out in his free time. Discover more about Lukas in our blog: https://bit.ly/4gMl3BN #HSEAG #InsideHSE #HSELife

Metric
Company Name	HSE•AG	Open Text Corporation	Urbint
Symbol		OTEX
MSH ID	COM:HSEAG	COM:OPENTEXT	COM:URBINT
Market	PRIVATE	STOCKS	PRIVATE
Sector	Commercial & Professional Services	Technology	Energy
Industry	Biotechnology	Software - Application	Technology
Country	CH	CA	US
Stage
Employee Count		23.70K	96
Website	hseag.com	opentext.com	urbint.com
LinkedIn	hombrechtikon-systems-engineering-ag		urbint
Founders

Metric
Market Cap		8.28B
Enterprise Value
Monthly Web Traffic	2.10K
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue		5.77B
Revenue (LTM)
Revenue (NTM)
Gross Profit		4.43B
EBITDA		1.57B
Operating Income		1.01B
Net Income		465.09M
EPS		1.71
Diluted EPS		1.71
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.73
Operating Profit Margin		0.16
EBITDA Margin		0.27
Net Profit Margin		0.08
Return on Equity		0.11
Return on Assets		0.03
Return on Capital Employed		0.08

HSEA

COM:HSEAG

HSE•AG

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		32.61
P/B Ratio		2.83
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		1.88
EV Multiple		2.02

Metric
Days Sales Outstanding		59.55
Days Payables Outstanding		34.49
Days Inventory Outstanding		485.02
Operating Cycle		530.47
Cash Conversion Cycle		495.07
Asset Turnover		0.41

Metric
Operating Cash Flow		967.69M
Free Cash Flow		808.40M
Cash Flow to Debt		0.15
Operating Cash Flow/Sales		0.17
Free Cash Flow Yield		0.05

Metric
Cash & Equivalents		1.28B
Accounts Receivable		13.16M
Inventory		1
Goodwill		7.49B
Debt to Capitalization		0.69
Debt to Assets		0.55
Current Ratio		0.69
Quick Ratio		0.81

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.03
R&D to Revenue		0.16
SG&A to Revenue		0.09